CRKL Antibody (N-term) Blocking peptide
€363.00
In stock
SKU
AC-BP13545a
Background:
This gene encodes a protein kinase containing SH2 and SH3(src homology) domains which has been shown to activate the RAS andJUN kinase signaling pathways and transform fibroblasts in aRAS-dependent fashion. It is a substrate of the BCR-ABL tyrosinekinase, plays a role in fibroblast transformation by BCR-ABL, andmay be oncogenic.
Other Names:
Crk-like protein, CRKL
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13545a was selected from the N-term region of CRKL. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CRKL
Gene ID: 1399
Primary Accession: P46109
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
This gene encodes a protein kinase containing SH2 and SH3(src homology) domains which has been shown to activate the RAS andJUN kinase signaling pathways and transform fibroblasts in aRAS-dependent fashion. It is a substrate of the BCR-ABL tyrosinekinase, plays a role in fibroblast transformation by BCR-ABL, andmay be oncogenic.
Other Names:
Crk-like protein, CRKL
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13545a was selected from the N-term region of CRKL. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CRKL
Gene ID: 1399
Primary Accession: P46109
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review